Fulcrum Therapeutics, Inc.
US ˙ NasdaqGM ˙ US3596161097

SecurityFULC / Fulcrum Therapeutics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership315,185 shares
Latest Disclosed Value $ 2,417,469
UBS Group AG reports 206.10% increase in ownership of FULC / Fulcrum Therapeutics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 315,185 shares of Fulcrum Therapeutics, Inc. (US:FULC) valued at $2,417,469 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 102,967 shares of Fulcrum Therapeutics, Inc.. This represents a change in shares of 206.10% during the quarter. The current value of the position is $1,014,896 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F FULCRUM THERAPEUTICS COM 359616109 315,185 212,218 206.10 2,417 107.65 0.0001
2026-01-29 2025-12-31 13F FULCRUM THERAPEUTICS COM 359616109 102,967 -198,190 -65.81 1,165 -57.98 0.0000
2025-11-13 2025-09-30 13F FULCRUM THERAPEUTICS COM 359616109 301,157 165,952 122.74 2,771 197.85 0.0004
2025-08-14 2025-06-30 13F FULCRUM THERAPEUTICS COM 359616109 135,205 63,285 87.99 930 349.28 0.0002
2025-05-13 2025-03-31 13F FULCRUM THERAPEUTICS COM 359616109 71,920 -5,472 -7.07 207 -42.98 0.0000
2025-02-14 2024-12-31 13F FULCRUM THERAPEUTICS COM 359616109 77,392 -3,241 -4.02 364 26.48 0.0001
2024-11-14 2024-09-30 13F FULCRUM THERAPEUTICS COM 359616109 80,633 -109,918 -57.68 288 -75.70 0.0001
2024-08-14 2024-06-30 13F FULCRUM THERAPEUTICS COM 359616109 190,551 117,783 161.86 1,181 72.16 0.0003
2024-05-13 2024-03-31 13F FULCRUM THERAPEUTICS COM 359616109 72,768 42,585 141.09 687 237.93 0.0002
2024-02-09 2023-12-31 13F FULCRUM THERAPEUTICS COM 359616109 30,183 19,026 170.53 204 314.29 0.0001
2023-11-09 2023-09-30 13F FULCRUM THERAPEUTICS COM 359616109 11,157 -20,602 -64.87 50 -52.88 0.0000
2023-08-11 2023-06-30 13F FULCRUM THERAPEUTICS COM 359616109 31,759 31,335 7,390.33 105 10,300.00 0.0000
2023-05-12 2023-03-31 13F FULCRUM THERAPEUTICS COM 359616109 424 -3,365 -88.81 1 -96.30 0.0000
2023-02-08 2022-12-31 13F FULCRUM THERAPEUTICS COM 359616109 3,789 3,789 28 0.0000
2022-08-10 2022-06-30 13F FULCRUM THERAPEUTICS COM 359616109 0 -1,469 -100.00 0 -100.00
2022-05-16 2022-03-31 13F FULCRUM THERAPEUTICS COM 359616109 1,469 644 78.06 35 133.33 0.0000
2022-02-14 2021-12-31 13F FULCRUM THERAPEUTICS COM 359616109 825 -480 -36.78 15 -59.46 0.0000
2021-11-15 2021-09-30 13F FULCRUM THERAPEUTICS COM 359616109 1,305 363 38.54 37 270.00 0.0000
2021-08-13 2021-06-30 13F FULCRUM THERAPEUTICS COM 359616109 942 -579 -38.07 10 -44.44 0.0000
2021-05-12 2021-03-31 13F FULCRUM THERAPEUTICS COM 359616109 1,521 1,191 360.91 18 350.00 0.0000
2021-02-11 2020-12-31 13F FULCRUM THERAPEUTICS COM 359616109 330 -2,896 -89.77 4 -84.62 0.0000
2020-11-12 2020-09-30 13F FULCRUM THERAPEUTICS COM 359616109 3,226 -1,114 -25.67 26 -67.09 0.0000
2020-07-31 2020-06-30 13F FULCRUM THERAPEUTICS COM 359616109 4,340 -3,773 -46.51 79 -18.56 0.0000
2020-05-01 2020-03-31 13F FULCRUM THERAPEUTICS COM 359616109 8,113 2,006 32.85 97 -3.96 0.0000
2020-02-14 2019-12-31 13F FULCRUM THERAPEUTICS COM 359616109 6,107 1,664 37.45 101 248.28 0.0000
2019-11-14 2019-09-30 13F FULCRUM THERAPEUTICS COM 359616109 4,443 4,443 29 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.